Articles with public access mandates - Alexander PantelyatLearn more
Not available anywhere: 2
Review
Telemedicine use for movement disorders: a global survey
A Hassan, ER Dorsey, CG Goetz, BR Bloem, M Guttman, CM Tanner, ...
Telemedicine and e-Health 24 (12), 979-992, 2018
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Review
globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways
Y Jang, T Thuraisamy, J Redding-Ochoa, O Pletnikova, JC Troncoso, ...
Mandates: US National Institutes of Health
Available somewhere: 76
Review
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria
GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ...
Movement disorders 32 (6), 853-864, 2017
Mandates: US National Institutes of Health, German Research Foundation, Alzheimers's …
Review
Poly (ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
TI Kam, X Mao, H Park, SC Chou, SS Karuppagounder, GE Umanah, ...
Science 362 (6414), eaat8407, 2018
Mandates: US National Institutes of Health
Review
Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be?
JL Whitwell, GU Höglinger, A Antonini, Y Bordelon, AL Boxer, C Colosimo, ...
Movement Disorders 32 (7), 955-971, 2017
Mandates: US National Institutes of Health, German Research Foundation, Leibniz …
Review
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ...
Brain 143 (1), 234-248, 2020
Mandates: US National Institutes of Health, Alzheimers's UK, UK Medical Research …
Review
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
G Respondek, C Kurz, T Arzberger, Y Compta, E Englund, LW Ferguson, ...
Movement Disorders 32 (7), 995-1005, 2017
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Review
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
MJ Grimm, G Respondek, M Stamelou, T Arzberger, L Ferguson, E Gelpi, ...
Movement disorders 34 (8), 1228-1232, 2019
Mandates: US National Institutes of Health, German Research Foundation, UK Medical …
Review
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ...
Alzheimer's & Dementia 16 (1), 106-117, 2020
Mandates: US National Institutes of Health
Review
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the …
SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ...
Acta neuropathologica 138, 237-250, 2019
Mandates: US National Institutes of Health, Danish Council for Technology and …
Review
Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction
CA Ross, A Pantelyat, J Kogan, J Brandt
Movement disorders 29 (11), 1351-1358, 2014
Mandates: US National Institutes of Health
Review
Music therapy and music-based interventions for movement disorders
K Devlin, JT Alshaikh, A Pantelyat
Current Neurology and Neuroscience Reports 19, 1-13, 2019
Mandates: US National Institutes of Health
Review
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
E Jabbari, S Koga, RR Valentino, RH Reynolds, R Ferrari, MMX Tan, ...
The Lancet Neurology 20 (2), 107-116, 2021
Mandates: US National Institutes of Health, German Research Foundation, Alzheimers's …
Review
Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration
JC Rojas, P Wang, AM Staffaroni, C Heller, Y Cobigo, A Wolf, SYM Goh, ...
Neurology 96 (18), e2296-e2312, 2021
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Review
Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies
JT Geiger, J Ding, B Crain, O Pletnikova, C Letson, TM Dawson, ...
Neurobiology of disease 94, 55-62, 2016
Mandates: US National Institutes of Health
Review
Use of the CDR® plus NACC FTLD in mild FTLD: data from the ARTFL/LEFFTDS consortium
T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ...
Alzheimer's & Dementia, 2019
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Review
Best practices in the clinical management of progressive supranuclear palsy and corticobasal syndrome: a consensus statement of the CurePSP centers of care
B Bluett, AY Pantelyat, I Litvan, F Ali, D Apetauerova, D Bega, L Bloom, ...
Frontiers in neurology 12, 694872, 2021
Mandates: US National Institutes of Health
Review
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases
EM Ramos, DR Dokuru, V Van Berlo, K Wojta, Q Wang, AY Huang, ...
Alzheimer's & Dementia 16 (1), 118-130, 2020
Mandates: US National Institutes of Health
Review
DRUM‐PD: The use of a drum circle to improve the symptoms and signs of parkinson's disease (PD)
A Pantelyat, C Syres, S Reichwein, A Willis
Movement disorders clinical practice 3 (3), 243-249, 2016
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Review
Validation of the movement disorder society criteria for the diagnosis of 4‐repeat tauopathies
G Respondek, MJ Grimm, I Piot, T Arzberger, Y Compta, E Englund, ...
Movement disorders 35 (1), 171-176, 2020
Mandates: US National Institutes of Health, German Research Foundation, UK Medical …
Publication and funding information is determined automatically by a computer program